• Southeast Asia-based health technology company’s office serves as multi-disciplinary R&D hub to collaborate with research institutions in Singapore
• Innovations developed will strengthen EVYD Technology’s existing capabilities to convert healthcare data into actionable insights to drive better outcomes for healthcare stakeholders
• Planning to hire another 200 over the next 12 months as EVYD Technology expands beyond Southeast Asia to North America, Australia and New Zealand.
• Company organized the Special Ministerial Conference for Digital Public Health ASEAN 2021, plans to host second conference this October

SINGAPORE – Media OutReach – 17 May 2022 – EVYD Technology is pleased to officially open recently its office in Singapore. The four-floor 5,000 sq ft office, located in the Central Business District at 55 Tras Street, will be home to the Southeast Asia-based health technology company’s 50-strong team in the country.

EVYD Technology leverages big data and artificial intelligence (AI) to drive better outcomes for healthcare stakeholders. It offers three main suites of solutions:

• The flagship EVYDENCE data operating platform supports policymakers, health authorities, healthcare providers, payers and researchers to enhance the governance and usability of their data by enabling real-time data monitoring and traceability, flexible data access configuration, precise structured search, secure sandbox operations and third-party interoperability.
• The EVYDSurveillance public health surveillance platform is able to track and monitor the emergence and spread of over 30 infectious diseases in real-time.
• The EVYDHealth population health platform uses data to allow for the early detection of individuals at risk of chronic and critical diseases.

EVYD Technology was founded in April 2020 with a team of five and has grown to over 200 employees in two years across Singapore, Brunei, Beijing and Shanghai. The company aims to hire an additional 200 employees over the next 12 months as it accelerates research and development (R&D) and expands beyond Southeast Asia to North America, Australia and New Zealand.

Its Singapore office will also serve as a multi-disciplinary R&D hub. It aims to leverage its domain expertise in medicine, behavioral and implementation science, data science and design thinking to co-create, iterate and implement digital solutions for the population. This is part of EVYD Technology’s continued commitment to congregating the best talents locally and overseas, marrying innovation and learned experiences to build a compelling solution that will benefit the population.

“The COVID-19 pandemic has caused severe disruptions to many. Through big data processing and analysis, model building and data security technology and management, we worked closely with the Ministries of Health of both Singapore and Brunei to combat the pandemic, and demonstrated the value of our technology and capabilities. Because of this recognition of the value we provide, we have managed to scale our operations significantly over the last two years,” said Mr Chua Ming Jie, Chief Executive Officer of EVYD Technology.

“Our new office and multi-disciplinary R&D hub in Singapore will be able to tap on the country’s many strengths. These include the ready availability of multi-disciplinary talents, established data privacy laws, the multitude of prestigious research institutions, and Singapore’s track record of being a leader in healthcare transformation – the latest of which is the Healthier SG initiative and the move towards getting every resident to have a regular physician as part of a holistic push for healthier lifestyles and preventive care. All of these are part of the fertile environment that allows healthcare innovation to flourish.”

Annual Special Ministerial Conference for ASEAN Digital Public Health

As part of its commitment to optimizing the healthcare ecosystem, EVYD Technology joined hands with the Ministry of Finance and Economy, Ministry of Health and Brunei Investment Agency in Brunei, and Temasek Foundation in Singapore to organise the hybrid two-day Special Ministerial Conference for ASEAN Digital Public Health in October 2021, with over 50 speakers from around the world. In October this year, the company will organize the second edition of this conference, continuing its commitment to promoting digital public health for safer, better and more accessible healthcare systems in the world.

EVYD Technology provides a range of professional services for companies ranging from healthcare start-ups to national and global corporate organisations who need external support on technological infrastructure development and consulting solutions.

About EVYD Technology

EVYD Technology is a healthcare artificial intelligence (AI) and Big Data company with the mission to transform healthcare using data intelligence. Its solutions enable value-based healthcare that is safer, better and more accessible for global communities. It offers solutions to policymakers to enhance public health monitoring, generate insights for policymaking and implement initiatives such as value-based healthcare and population health management. It also offers solutions to the research community to enhance the efficiency and quality of their research, from which insights generated could be leveraged to benefit the broader ecosystem. The company’s flagship EVYDENCE operating platform aggregates raw data that reside in disparate information systems and convert them into computable, structured and standardised data so that they could be further processed to derive deep insights and knowledge using natural language processing, machine learning and other AI technologies. EVYD Technology is a Brunei Investment Agency investee company.

For more information, visit https://www.evydtech.com

#EVYDTechnology

HONG KONG SAR – Media OutReach – 17 May 2022 – Summer is around the corner. Ladies have to wear makeup and along with facial mask on, skin problems like imbalance in skin water and oil content, dryness, fine lines and so on can easily be found. Let alone pore blockage by consistently wearing a mask, and our skin age may look 10 years older than it should. The “LDM® Cell Skin Aesthetic Ace Treatment” exclusively designed by Pretty Beauty strengthens the treatment technology to be more effective with the needs of customers in summer. It activates cells from the deep layers of the skin, in order to achieve “brightening, delicate and shiny” young skin. LDM Treatment brings you peace of mind this summer. Let your healthy skin be reborn and transformed, showing your most glamorous moments of all time.

Patented LDM® Developed in Germany – A Medically Proven Treatment

“LDM® Cell Regenerator” is a beauty instrument imported by Pretty Beauty from overseas, developed by Wellcomet Technology in Germany. Through the patented LDM® technology (Local Dynamic Micro-Massage), two or three ultrasonic wavelengths are transmitted in alternating forms, which balance the extracellular matrix (ECMs) to regulate and decompose matrix metalloproteinases (MMPs), enhance glycosaminoglycans (GAGs) and produce heat shock proteins (HSPs). Lymph and blood circulation are improved and restore the skin with its natural plumpness. The skin’s hyaluronic acid (HA) levels are also stimulated by specific ultrasound frequencies, ultimately repairing damaged cells and rebuilding the collagen network. The glowing and rejuvenated skin is filled with energy and is ready for the summer. The LDM® Cell Regenerator is a solution to different skin problems. LDM-Noblesse® and LDM®-Triple can flexibly convert three different dual-wave combinations. The former one has the frequencies of 1/3 MHz, 3/10 MHz and 1/10 MHz, while the latter one has 1/3/10 MHz or 3/10/19 MHz. They are meant to cover every inch of subcutaneous tissue and epidermal cells, repairing aging cells from the root and activating the skin’s natural regeneration. Skin tightening effects are instant and it improves overall facial quality and texture problems.

Skin Strengthening Treatment – Embrace the Summer

Pretty Beauty stated that the strengthening treatment adjustment is a the strengthening to a complete treatment course, so that the treatment course can cater the needs of skin in the summertime. LDM® Cell Skin Aesthetic Ace Treatment is not just equipped with the three ultrasonic frequencies from shallow to deep 1/3/10MHZ, but also the 3/10/19MHZ three-frequency mode which further improves the epidermal skin problems. It transmits the ultrasound to the dermis skin at the depth of 0.3cm to achieve the effect of wrinkle reduction, and at the same time deals with the common summer skin issues like acne and imbalance in skin water and oil content.

Painless and Non-invasive – Building the Foundation of Youthful Skin

Pretty Beauty’s “LDM® Cell Skin Aesthetic Ace Treatment” uses ultrasonic energy to efficiently activate, repair and awaken subcutaneous cells in a painless and side-effect-free manner. It deeply repairs damaged cells, replenishes abundant moisture and nutrients to skin cells, and improves the protection to the skin surface. Not only does it keep the skin delicate and glowing at all times, it also improves skin problems such as acne, uneven skin tone, enlarged pores, dryness, and fine lines, etc. Ultimately it helps maintain firmness and youthfulness, keep the bounciness of skin, and slow down skin aging.

In addition, the LDM® Cell Regenerator has more than 10 kinds of predetermined skin care procedures to repair damaged cells for various skin problems, including eczema, acne, dermatitis, proliferative scars, connective tissue problems and other lasting skin symptoms. It is an equation to revitalize healthy skin by combining the principles of thermal, biochemistry and kinetics. It penetrates deeply into the dermis layer of the skin and destroys damaged cells to trigger structural repair. Youthfulness is restored in just 28 days.

About Pretty Beauty Group

Pretty Beauty Group was established in the year of 1985. It has been specializing in beauty and body shaping services for 37 years. It has rich experiences in the beauty industry and is the first to introduce the latest technology and equipment from time to time! Pretty Beauty Group currently has 16 branches in Hong Kong, dedicated to providing professional, safe, reliable and attentive beauty and slimming experience for ladies who love beauty. To learn more about beauty, skin, and body shape treatments, please visit https://prettybeautygroup.com.

#PrettyBeauty

The issuer is solely responsible for the content of this announcement.

• THE ROUNDUP, a sequel to the 2017 box office hit THE OUTLAWS starring Spackman Media Group artist Son Suk-ku, ranks #1 in national box office ticket reservations in Korea
• THE ROUNDUP was pre-sold to 132 countries around the world, including Singapore, China, Thailand, Vietnam, Indonesia and France, as well as the regions of North America and Eastern Europe
• THE ROUNDUP, which is to be released in Korean theatres on May 18, held a pre-release screening at major theatres of CGV, Lotte Cinema, and Megabox for two days from May 14 to May 15

SINGAPORE – Media OutReach – 16 May 2022 – Spackman Entertainment Group Limited (the “Group“), one of Korea’s leading entertainment production groups founded in 2011 by media & technology investor Charles Spackman, wishes to announce that the THE ROUNDUP, a sequel to the 2017 box office hit THE OUTLAWS starring Son Suk-ku of the Group’s associated company, Spackman Media Group Limited (“Spackman Media Group“), dominates Korea’s box office ticket reservations at 62%, according to data from the Korean Film Council.

THE ROUNDUP was pre-sold to 132 countries around the world, including Singapore, China, Thailand, Vietnam, Indonesia and France, as well as the regions of North America and Eastern Europe.

Previously, the Group’s subsidiary, Novus Mediacorp Co., Ltd., co-presented and distributed the 2017 box office hit THE OUTLAWS. THE OUTLAWS broke the all-time highest Video On Demand sales record in Korea in 2018.

Alongside Ma Dong-seok (Don Lee) of Marvel Studios’ ETERNALS (2021), Son Suk-ku headlines in THE ROUNDUP, which is scheduled to premiere on May 18. THE ROUNDUP held a pre-release screening at major theatres of CGV, Lotte Cinema, and Megabox for two days from May 14 to 15.

In the film, Son Suk-ku takes on the role of extreme villain Kang Hae-sang where he confronts Detective Ma Suk-do, played by Ma Dong-seok.

THE ROUNDUP is also directed by Kang Yoon-sung of THE OUTLAWS.

Son Suk-ku is represented by SBD Entertainment Inc. (“SBD Entertainment“), a wholly-owned subsidiary of Spackman Media Group.

Son Suk-ku of SBD Entertainment starred in the romance comedy film, NOTHING SERIOUS (2021), which reached #1 at the box office in Korea last year, and K-dramas, Netflix’s D.P. (2021), DESIGNATED SURVIVOR: 60 DAYS (2019) and MATRIMONIAL CHAOS (2018). He also starred in the American Netflix drama series SENSE8, which was written and produced by the Wachowski sisters.

Other than Son Suk-ku, SBD Entertainment also represents one of Korea’s rapidly rising young actors, Han Ji-hyun of popular K-drama THE PENTHOUSE 3, who won the Best Rookie Female Actor in the 2021 Brand Customer Loyalty Awards in Korea and endorsed luxury brand Gucci in April 2021.

About Spackman Entertainment Group Limited

Spackman Entertainment Group Limited (“SEGL” or the “Company“), and together with its subsidiaries, (the “Group“), is one of Korea’s leading entertainment production groups. SEGL is primarily engaged in the independent development, production, presentation, and financing of theatrical motion pictures in Korea.

The Company was founded in 2011 by renowned media and technology investor Charles Spackman who served as the Company’s Executive Chairman until 2017. For the past two decades, Mr. Charles Spackman has been a powerhouse in the Korean entertainment industry starting in the early 2000’s with the pioneering success of Sidus Pictures, the largest movie production company at the time and the first to be listed in Korea. Mr. Spackman is also the Founder, Chairman and Chief Executive Officer of the global investment firm, Spackman Group. For more information, please visit http://www.charlesspackman.com and https://spackman-group.com/charles-spackman.

Since its founding, SEGL had produced more than 30 major motion pictures including a number of the highest grossing and award-winning films in Korea, namely #ALIVE (2020), CRAZY ROMANCE (2019), DEFAULT (2018), MASTER (2016), THE PRIESTS (2015), SNOWPIERCER (2013), COLD EYES (2013) and ALL ABOUT MY WIFE (2012).

Our films are theatrically distributed and released in Korea and overseas markets, as well as for subsequent post-theatrical worldwide release in other forms of media, including online streaming, cable TV, broadcast TV, IPTV, video-on-demand, and home video/DVD, etc. Generally, we release our motion pictures into wide-theatrical exhibition initially in Korea, and then in overseas and ancillary markets.

The Group also invests into and produces Korean television dramas. In addition to our content business, we also own equity stakes in entertainment-related companies and film funds that can financially and strategically complement our existing core operations. SEGL is listed on the Catalist of the Singapore Exchange Securities Trading Limited under the ticker 40E.

Production Labels

SEGL owns Novus Mediacorp Co., Ltd. (“Novus Mediacorp“), an investor, presenter, and/or post-theatrical distributor for a total of 79 films (58 Korean and 21 foreign) including ROSE OF BETRAYAL, THE OUTLAWS and SECRETLY, GREATLY, which was one of the biggest box office hits of 2013 starring Kim Soo-hyun of MY LOVE FROM THE STARS, as well as FRIEND 2: THE GREAT LEGACY. In 2012, Novus Mediacorp was also the post-theatrical rights distributor of ALL ABOUT MY WIFE, a top-grossing romantic comedy produced by Zip Cinema. In 2018, THE OUTLAWS, co-presented by Novus Mediacorp broke the all-time highest Video On Demand (“VOD“) sales records in Korea. For more information, please visit http://novusmediacorp.com

The Company owns a 100% equity interest in Simplex Films Limited (“Simplex Films“) which is an early stage film production firm. The maiden film of Simplex Films, JESTERS: THE GAME CHANGERS (2019), was released in Korea on 21 August 2019. Simplex Films has several line-up of films including HURRICANE BROTHERS (working title).

The Company owns a 100% equity interest in Take Pictures Pte. Ltd. (“Take Pictures“) which produced STONE SKIPPING (2020) and THE BOX (2021), and shall release THE GUEST in the second half of 2022 and A MAN OF REASON, with the previous working title GUARDIAN in 2022 tentatively.

The Company owns a 100% equity interest in Greenlight Content Limited (“Greenlight Content“) which is mainly involved in the business of investing into dramas and movies, as well as providing consulting services for the production of Korean content. Through the acquisition of Greenlight Content, the Group’s first co-produced drama, MY SECRET TERRIUS, starring top Korean star, So Ji Sub, achieved #1 in drama viewership ratings for its time slot and recorded double digits for its highest viewership ratings. Greenlight Content was one of the main investors of MY SECRET TERRIUS.

The Company owns a 20% equity interest in The Makers Studio Co. Ltd., which plans to produce and release four upcoming films, the first of which will be THE ISLAND OF THE GHOST’S WAIL, a comedy horror film.

Talent Representation

The Company holds an effective shareholding interest of 43.88% in Spackman Media Group Limited (“SMGL“). SMGL, a company incorporated in Hong Kong, together with its subsidiaries, is collectively one of the largest entertainment talent agencies in Korea in terms of the number of artists under management, including some of the top names in the Korean entertainment industry. SMGL operates its talent management business through renowned agencies such as MSteam Entertainment Co., Ltd. (Son Ye-jin, Wi Ha-jun, Lee Min-jung, Ko Sung-hee), SBD Entertainment Inc. (Son Suk-ku, Han Ji-hyun, Lee Cho-hee, Park Keun-rok), UAA&CO Inc. (Kim Sang-kyung, Kim Hye-ri, Kim Ji-young, Wang Ji-won), Play Content Co., Ltd. (Kang Min-ji, Hwang-hwi) and Kook Entertainment Co., Ltd. (Baek Si-won, Shin Ji-woong). Through these full-service talent agencies in Korea, SMGL represents and guides the professional careers of a leading roster of award-winning actors/actresses in the practice areas of motion pictures, television, commercial endorsements, and branded entertainment. SMGL leverages its unparalleled portfolio of artists as a platform to develop, produce, finance and own the highest quality of entertainment content projects, including theatrical motion pictures, variety shows and TV dramas. This platform also creates and derives opportunities for SMGL to make strategic investments in development stage businesses that can collaborate with SMGL artists. SMGL is an associated company of the Company. For more information, please visit http://www.spackmanmediagroup.com

The Company owns a 100% equity interest in Constellation Agency Pte. Ltd. (“Constellation Agency“). Constellation Agency, which owns The P Factory Co., Ltd. (“The P Factory“) and Platform Media Group Co., Ltd. (“PMG“), is primarily involved in the business of overseas agency for Korean artists venturing into the overseas market. The P Factory is an innovative marketing solutions provider specializing in event and branded content production. PMG is a talent management agency which represents and manages the careers of major artists in film, television, commercial endorsements and branded entertainment.

Strategic Businesses

The Company also operates a café-restaurant, Upper West, in the Gangnam district of Seoul and own a professional photography studio, noon pictures Co., Ltd.

For more details, please visit http://www.spackmanentertainmentgroup.com/

#SpackmanEntertainmentGroup